跳至主要内容
临床试验/NL-OMON21320
NL-OMON21320已完成不适用

Efficacy of peripherally targeted inhaled rhDNase for persistent obstructive asthma in childhood.

ErasmusMC Rotterdam0 个研究点目标入组 60 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
60

研究概览

简要总结

  1. Fuchs, H.J., et al., Effect of aerosolized recombinant human DNase on exacerbations of respiratory symptoms and on pulmonary function in patients with cystic fibrosis. The Pulmozyme Study Group. N Engl J Med, 1994. 331(10): p. 637-42. 2. King, M., et al., Rheology of cystic fibrosis sputum after in vitro treatment with hypertonic saline alone and in combination with recombinant human deoxyribonuclease I. Am J Respir Crit Care Med, 1997. 156(1): p. 173-7. 3. Hodson, M.E. and P.L. Shah, DNase trials in cystic fibrosis. Eur Respir J, 1995. 8(10): p. 1786-91. 4. Greally, P., Human recombinant DNase for mucus plugging in status asthmaticus. Lancet, 1995. 346(8987): p. 1423-4 5. Durward, A., V. Forte, and S.D. Shemie, Resolution of mucus plugging and atelectasis after intratracheal rhDNase therapy in a mechanically ventilated child with refractory status asthmaticus. Crit Care Med, 2000. 28(2): p. 560-2.

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1. Age 6 – 18 years;
  • 2. Asthma diagnosed according to GINA guidelines;

排除标准

  • 1. Asthma exacerbation with hospital admission in last 3 months;
  • 2. Intensive Care Unit (ICU) admission for asthma within the last year;

研究者

发起方
ErasmusMC Rotterdam

相似试验

已完成
不适用
Peripheral targeting of inhaled rhDNase in stable CF patients.Cystic Fibrosis, rhDNase (Pulmozyme), inhalation, airways.
NL-OMON23855Investigator initiated study.Initiator: Harm Tiddens, M.D. PhD.ErasmusMC - Sophia Children's Hospital50
已完成
不适用
DIEPTE-study: DNase Inhalation in cf Exacerbations, Peripherally Targeted.
NL-OMON25231Roche Nederland B.V.40
进行中(未招募)
不适用
Efficacy of peripherally targeted inhaled rhDNase for persistent obstructive asthma in childhoodAsthma is a chronic inflammatory disorder in which many cells play a role, in particular mast cells, eosinophils and T lymphocytes. In susceptible individuals this inflammation causes recurrent episodes of wheezing, breathlessness, chest tightness and cough. These symptoms are usually associated with widespread but variable airflow limitation that is at least partly reversible either spontaneously or with treatment.MedDRA version: 8.1Level: LLTClassification code 10003553Term: Asthma
EUCTR2006-002337-20-NLErasmus Medical Centre Rotterdam60
已完成
不适用
Efficacy of peripherally targeted inhaled rhDNase for persistent obstructive asthma in childhoodObstructive pulmonary function, asthmaRespiratoryObstructive pulmonary disease, asthma
ISRCTN71537084Erasmus Medical Center (The Netherlands)60
已完成
不适用
Efficacy of Inhaled RhDNase in Mechanically Ventilated Pediatric Patients with an Atelectasis.Atelectasis during mechanical ventilation.
NL-OMON21415Erasmus Medical Center, Sophia Children's Hospital. Dr. Molewaterplein 60, 3015 GJ Rotterdam80